Dendreon Surges 10% on Takeover Chatter

Shares of Dendreon

are seeing increased strength during Wednesday's trading session after unconfirmed rumors began circulating. The rumors going around the Street state that global and diversified healthcare company Sanofi

may be looking to acquire Dendreon for $12 per share. However, these are just unconfirmed stock chatter. Benzinga contacted both Dendreon and Sanofi, and has not heard back. Currently, shares of Dendreon are trading up about 10% at $6.89 per share.